James D. Marks

Professor at University of California - San Francisco

James D. Marks

James D. Marks

Professor at University of California - San Francisco

Overview
Career Highlights

Migs LLC
Hermes Biosciences, Inc.

RelSci Relationships

2068

Number of Boards

4

Relationships
RelSci Relationships are individuals James D. Marks likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Adimab LLC

Relationship likelihood: Strong

Chief Executive Officer & Director at Rheos Medicines, Inc.

Relationship likelihood: Strong

Founder at Alector, Inc.

Relationship likelihood: Strong

Co-Founder at Adimab LLC

Relationship likelihood: Strong

Co-Founder at ImaginAb, Inc.

Relationship likelihood: Strong

Chairman, Department of Immunology & Microbial Science at The Scripps Research Institute

Relationship likelihood: Strong

Member, Scientific Advisory Board at Exeltis USA Dermatology, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at Adimab LLC

Relationship likelihood: Strong

Member, Scientific Advisory Board at Exeltis USA Dermatology, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at Exeltis USA Dermatology, Inc.

Relationship likelihood: Strong

Paths to James D. Marks
Potential Connections via
Relationship Science
You
James D. Marks
Professor at University of California - San Francisco
Career History
Professor
Current

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Professor, Departments of Anesthesia & Pharmaceutical Chemistry
Current
Professor of Anesthesia
Tenure Unconfirmed

University of California Berkeley National rankings: In a National Research Council analysis of 212 doctoral programs at American universities, 48 Berkeley programs place among the top 10 nationwide. Faculty awards and honors: There are 8 Nobel Laureates, 32 MacArthur Fellows, and 4 Pulitzer Prize winners among the current faculty. History of UC Berkeley: Historical highlights, arranged by topic, following the campus's development — from UC's founding in 1868 to a turn-of-the-century building boom, a research explosion in the 1930s, the Free Speech Movement of the '60s, and Berkeley's key role today in science and technology revolutions. Timeline of discoveries and contributions by UC Berkeley scholars. Traditions of Cal: Who was the Angel of Death? What's with the "Big C" up there in the hills — and why is it sometimes green? Who wears Oski's jolly bear head and size 54 yellow sweater? Tours and webcams: Check out what's happening on Sproul Plaza, the campus's true heart. See stunning live views of the Bay Area from the Lawrence Hall of Science's perch in the Berkeley hills. Chancellor and administration: Information on Chancellor Robert Birgeneau, Executive Vice Chancellor and Provost George W. Breslauer, and how the university is organized. Organizational charts are included. UC System overview and links: On the campuses, laboratories, and medical centers that comprise UC's public educational system, as well as UC's K-12 partnerships, economic impact, and agriculture and environmental resources.

Boards & Committees
Member, Scientific Advisory Board
Current

Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH.

Member, Scientific Advisory Board
Current

Exeltis USA Dermatology, Inc. engages in the development and sale of prescription drugs and pharmaceutical products. It utilizes technology platforms to address a variety of skin and wound disorders. The company was founded by Jeffrey S. Day in 2005 and is headquartered in Florham Park, NJ.

Member, Scientific Advisory Board
Prior - 2018

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

Political Donations
$500
2012

Former President of United States

$250
2008

Former President of United States

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James D. Marks. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James D. Marks's profile does not indicate a business or promotional relationship of any kind between RelSci and James D. Marks.